Micro 25 – Enterobacteriaceae

This episode introduces the large and clinically dominant family of Gram-negative rods known as the Enterobacteriaceae. Drawing from Murray’s Chapter 25, it explores organisms that primarily inhabit the gastrointestinal tract but frequently emerge as major pathogens.The narrative frames this family as biologically coherent: facultative anaerobes, oxidase-negative, glucose-fermenting rods possessing lipopolysaccharide in their outer membrane. From this shared structural foundation emerge diverse clinical personalities.Escherichia coli becomes the prototype - harmless intestinal resident in one context, urinary tract pathogen or toxin-producing enteric disruptor in another. The episode then expands to Klebsiella, Enterobacter, Serratia, and other opportunistic hospital-associated organisms, highlighting capsules, biofilm formation, and antimicrobial resistance.Pathotypes of diarrhoeagenic E. coli, endotoxin-mediated sepsis, and the role of plasmid-mediated resistance are integrated into a coherent clinical framework.Conceptually, this chapter emphasises ecological proximity: organisms native to the gut are uniquely positioned to cause disease when anatomical barriers fail. Clinically, it reinforces the importance of source control, resistance surveillance, and understanding endotoxin physiology.Key Takeaways* Enterobacteriaceae are Gram-negative, facultative anaerobic rods* Many are normal gut flora but opportunistic pathogens* Endotoxin contributes to systemic inflammatory response* Capsules and plasmids enhance virulence and resistance* Clinical syndromes range from UTI to septic shock This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe